122 related articles for article (PubMed ID: 17360832)
1. Metabolism, pharmacokinetics, and excretion of the substance P receptor antagonist CP-122,721 in humans: structural characterization of the novel major circulating metabolite 5-trifluoromethoxy salicylic acid by high-performance liquid chromatography-tandem mass spectrometry and NMR spectroscopy.
Colizza K; Awad M; Kamel A
Drug Metab Dispos; 2007 Jun; 35(6):884-97. PubMed ID: 17360832
[TBL] [Abstract][Full Text] [Related]
2. Structural characterization of urinary metabolites of the antiarrhythmic drug encainide in human subjects.
Jajoo HK; Mayol RF; LaBudde JA; Blair IA
Drug Metab Dispos; 1990; 18(1):28-35. PubMed ID: 1970774
[TBL] [Abstract][Full Text] [Related]
3. Excretion and biotransformation of cisapride in rats after oral administration.
Meuldermans W; Hendrickx J; Lauwers W; Hurkmans R; Mostmans E; Swysen E; Bracke J; Knaeps A; Heykants J
Drug Metab Dispos; 1988; 16(3):410-9. PubMed ID: 2900733
[TBL] [Abstract][Full Text] [Related]
4. Excretion and biotransformation of cisapride in dogs and humans after oral administration.
Meuldermans W; Van Peer A; Hendrickx J; Lauwers W; Swysen E; Bockx M; Woestenborghs R; Heykants J
Drug Metab Dispos; 1988; 16(3):403-9. PubMed ID: 2900732
[TBL] [Abstract][Full Text] [Related]
5. Absorption, metabolism and excretion of ketanserin in man after oral administration.
Meuldermans W; Hendrickx J; Woestenborghs R; Van Peer A; Lauwers W; De Cree J; Heykants J
Arzneimittelforschung; 1988 Jun; 38(6):789-94. PubMed ID: 3178919
[TBL] [Abstract][Full Text] [Related]
6. Metabolism of the antianxiety drug buspirone in human subjects.
Jajoo HK; Mayol RF; LaBudde JA; Blair IA
Drug Metab Dispos; 1989; 17(6):634-40. PubMed ID: 2575499
[TBL] [Abstract][Full Text] [Related]
7. Metabolism of bepridil in laboratory animals and humans.
Wu WN; Hills JF; Chang SY; Ng KT
Drug Metab Dispos; 1988; 16(1):69-77. PubMed ID: 2894958
[TBL] [Abstract][Full Text] [Related]
8. The biotransformation of (6,7-dichloro-2-methyl-1-oxo-2-phenyl-5-indanyloxy) acetic acid (MK-196) in the chimpanzee.
Zacchei AG; Wishousky TI; Arison BH; Fanelli GM
Drug Metab Dispos; 1976; 4(5):479-89. PubMed ID: 10148
[TBL] [Abstract][Full Text] [Related]
9. Metabolism of the calcium antagonist gallopamil in man.
Weymann J; Bühler V; Hege HG; Müller-Peltzer H; Schenk G; Stieren B; Hollmann M
Arzneimittelforschung; 1989 May; 39(5):605-7. PubMed ID: 2757679
[TBL] [Abstract][Full Text] [Related]
10. Metabolism of the antianxiety drug buspirone in the rat.
Jajoo HK; Mayol RF; LaBudde JA; Blair IA
Drug Metab Dispos; 1989; 17(6):625-33. PubMed ID: 2575498
[TBL] [Abstract][Full Text] [Related]
11. Metabolic disposition of trimetrexate, a nonclassical dihydrofolate reductase inhibitor, in rat and dog.
Wong BK; Woolf TF; Chang T; Whitfield LR
Drug Metab Dispos; 1990; 18(6):980-6. PubMed ID: 1981548
[TBL] [Abstract][Full Text] [Related]
12. Disposition, metabolism, and excretion of the anticancer agent crisnatol in the rat.
Patel DK; Woolley JL; Shcokcor JP; Johnson RL; Taylor LC; Sigel CW
Drug Metab Dispos; 1991; 19(2):491-7. PubMed ID: 1676660
[TBL] [Abstract][Full Text] [Related]
13. The metabolism and disposition of 14C-fenofibrate in human volunteers.
Weil A; Caldwell J; Strolin-Benedetti M
Drug Metab Dispos; 1990; 18(1):115-20. PubMed ID: 1970770
[TBL] [Abstract][Full Text] [Related]
14. Excretion and biotransformation of alfentanil and sufentanil in rats and dogs.
Meuldermans W; Hendrickx J; Lauwers W; Hurkmans R; Swysen E; Thijssen J; Timmerman P; Woestenborghs R; Heykants J
Drug Metab Dispos; 1987; 15(6):905-13. PubMed ID: 2893720
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the major metabolites of flavone acetic acid and comparison of their disposition in humans and mice.
Cummings J; Double JA; Bibby MC; Farmer P; Evans S; Kerr DJ; Kaye SB; Smyth JF
Cancer Res; 1989 Jul; 49(13):3587-93. PubMed ID: 2731178
[TBL] [Abstract][Full Text] [Related]
16. The metabolic pathways of tianeptine, a new antidepressant, in healthy volunteers.
Grislain L; Gele P; Bertrand M; Luijten W; Bromet N; Salvadori C; Kamoun A
Drug Metab Dispos; 1990; 18(5):804-8. PubMed ID: 1981739
[TBL] [Abstract][Full Text] [Related]
17. Metabolism of the antipsychotic drug tiospirone in humans.
Mayol RF; Jajoo HK; Klunk LJ; Blair IA
Drug Metab Dispos; 1991; 19(2):394-9. PubMed ID: 1676643
[TBL] [Abstract][Full Text] [Related]
18. Identification of the main urinary metabolites of omeprazole after an oral dose to rats and dogs.
Hoffmann KJ
Drug Metab Dispos; 1986; 14(3):341-8. PubMed ID: 2872036
[TBL] [Abstract][Full Text] [Related]
19. Metabolism and disposition of clarithromycin in man.
Ferrero JL; Bopp BA; Marsh KC; Quigley SC; Johnson MJ; Anderson DJ; Lamm JE; Tolman KG; Sanders SW; Cavanaugh JH
Drug Metab Dispos; 1990; 18(4):441-6. PubMed ID: 1976065
[TBL] [Abstract][Full Text] [Related]
20. The metabolism of nicardipine hydrochloride in healthy male volunteers.
Rush WR; Alexander O; Hall DJ; Cairncross L; Dow RJ; Graham DJ
Xenobiotica; 1986 Apr; 16(4):341-9. PubMed ID: 3716455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
